Cancer testes antigens in breast cancer

Biological role, regulation, and therapeutic applicability

Apurva Pandey, Abhishek Kurup, Arpan Shrivastava, Saba Radhi, Diane D. Nguyen, Candy Arentz, Nicholas D'Chuna, Fred Hardwick, Martin J. D'Souza, Marjorie Jenkins, Fabio Grizzi, W. Martin Kast, Everardo Cobos, Rakhshanda Rahman, Maurizio Chiriva-Internati, Raffaella Chiaramonte, Natalia Platonova

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Breast cancer remains one of the leading causes of death among women across the world. The last few decades have seen significant reduction in mortality owing to earlier detection and better adjuvant treatments that were developed based on clinical staging and morphological features. As these treatments have evolved, the heterogeneity of breast cancer poses a new challenge, since there is no standard gold-therapy suitable for all tumors of the mammary gland. Therefore, contemporary management and research efforts are directed toward specific prognostic and predictive molecular signatures that can guide targeted individualized therapy. The goal of ongoing research in this field is to identify specific molecular targets for developing novel therapeutic approaches. These targets can also serve to improve screening of breast cancer. This review focuses on the role of cancer testis antigens (CTAs) in breast carcinogenesis and explores the potential for development of targeted screening and therapeutic approaches. Normally found in the testes, these antigens are highly correlative with cancers of the breast, skin, and ovaries. These implications have been further corroborated through uncovering the interaction of CTAs with genes and proteins involved in tumor suppression and homeostasis like p53. There is some evidence that these genes can be targeted for early detection in addition to being candidates for cancer immunotherapy.

Original languageEnglish (US)
Pages (from-to)302-320
Number of pages19
JournalInternational Reviews of Immunology
Volume31
Issue number5
DOIs
StatePublished - Oct 2012

Fingerprint

Testicular Neoplasms
Breast Neoplasms
Antigens
Therapeutics
Neoplasms
Skin Neoplasms
Human Mammary Glands
Research
Gold
Ovarian Neoplasms
Immunotherapy
Testis
Cause of Death
Carcinogenesis
Breast
Homeostasis
Mortality
Genes
Proteins

Keywords

  • Biomarker
  • Breast cancer
  • Cancer testis antigen
  • Cancer vaccine
  • Immunotherapy

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Pandey, A., Kurup, A., Shrivastava, A., Radhi, S., Nguyen, D. D., Arentz, C., ... Platonova, N. (2012). Cancer testes antigens in breast cancer: Biological role, regulation, and therapeutic applicability. International Reviews of Immunology, 31(5), 302-320. https://doi.org/10.3109/08830185.2012.723511

Cancer testes antigens in breast cancer : Biological role, regulation, and therapeutic applicability. / Pandey, Apurva; Kurup, Abhishek; Shrivastava, Arpan; Radhi, Saba; Nguyen, Diane D.; Arentz, Candy; D'Chuna, Nicholas; Hardwick, Fred; D'Souza, Martin J.; Jenkins, Marjorie; Grizzi, Fabio; Kast, W. Martin; Cobos, Everardo; Rahman, Rakhshanda; Chiriva-Internati, Maurizio; Chiaramonte, Raffaella; Platonova, Natalia.

In: International Reviews of Immunology, Vol. 31, No. 5, 10.2012, p. 302-320.

Research output: Contribution to journalArticle

Pandey, A, Kurup, A, Shrivastava, A, Radhi, S, Nguyen, DD, Arentz, C, D'Chuna, N, Hardwick, F, D'Souza, MJ, Jenkins, M, Grizzi, F, Kast, WM, Cobos, E, Rahman, R, Chiriva-Internati, M, Chiaramonte, R & Platonova, N 2012, 'Cancer testes antigens in breast cancer: Biological role, regulation, and therapeutic applicability', International Reviews of Immunology, vol. 31, no. 5, pp. 302-320. https://doi.org/10.3109/08830185.2012.723511
Pandey, Apurva ; Kurup, Abhishek ; Shrivastava, Arpan ; Radhi, Saba ; Nguyen, Diane D. ; Arentz, Candy ; D'Chuna, Nicholas ; Hardwick, Fred ; D'Souza, Martin J. ; Jenkins, Marjorie ; Grizzi, Fabio ; Kast, W. Martin ; Cobos, Everardo ; Rahman, Rakhshanda ; Chiriva-Internati, Maurizio ; Chiaramonte, Raffaella ; Platonova, Natalia. / Cancer testes antigens in breast cancer : Biological role, regulation, and therapeutic applicability. In: International Reviews of Immunology. 2012 ; Vol. 31, No. 5. pp. 302-320.
@article{0927cc2970f7446da39340b309637927,
title = "Cancer testes antigens in breast cancer: Biological role, regulation, and therapeutic applicability",
abstract = "Breast cancer remains one of the leading causes of death among women across the world. The last few decades have seen significant reduction in mortality owing to earlier detection and better adjuvant treatments that were developed based on clinical staging and morphological features. As these treatments have evolved, the heterogeneity of breast cancer poses a new challenge, since there is no standard gold-therapy suitable for all tumors of the mammary gland. Therefore, contemporary management and research efforts are directed toward specific prognostic and predictive molecular signatures that can guide targeted individualized therapy. The goal of ongoing research in this field is to identify specific molecular targets for developing novel therapeutic approaches. These targets can also serve to improve screening of breast cancer. This review focuses on the role of cancer testis antigens (CTAs) in breast carcinogenesis and explores the potential for development of targeted screening and therapeutic approaches. Normally found in the testes, these antigens are highly correlative with cancers of the breast, skin, and ovaries. These implications have been further corroborated through uncovering the interaction of CTAs with genes and proteins involved in tumor suppression and homeostasis like p53. There is some evidence that these genes can be targeted for early detection in addition to being candidates for cancer immunotherapy.",
keywords = "Biomarker, Breast cancer, Cancer testis antigen, Cancer vaccine, Immunotherapy",
author = "Apurva Pandey and Abhishek Kurup and Arpan Shrivastava and Saba Radhi and Nguyen, {Diane D.} and Candy Arentz and Nicholas D'Chuna and Fred Hardwick and D'Souza, {Martin J.} and Marjorie Jenkins and Fabio Grizzi and Kast, {W. Martin} and Everardo Cobos and Rakhshanda Rahman and Maurizio Chiriva-Internati and Raffaella Chiaramonte and Natalia Platonova",
year = "2012",
month = "10",
doi = "10.3109/08830185.2012.723511",
language = "English (US)",
volume = "31",
pages = "302--320",
journal = "International Reviews of Immunology",
issn = "0883-0185",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Cancer testes antigens in breast cancer

T2 - Biological role, regulation, and therapeutic applicability

AU - Pandey, Apurva

AU - Kurup, Abhishek

AU - Shrivastava, Arpan

AU - Radhi, Saba

AU - Nguyen, Diane D.

AU - Arentz, Candy

AU - D'Chuna, Nicholas

AU - Hardwick, Fred

AU - D'Souza, Martin J.

AU - Jenkins, Marjorie

AU - Grizzi, Fabio

AU - Kast, W. Martin

AU - Cobos, Everardo

AU - Rahman, Rakhshanda

AU - Chiriva-Internati, Maurizio

AU - Chiaramonte, Raffaella

AU - Platonova, Natalia

PY - 2012/10

Y1 - 2012/10

N2 - Breast cancer remains one of the leading causes of death among women across the world. The last few decades have seen significant reduction in mortality owing to earlier detection and better adjuvant treatments that were developed based on clinical staging and morphological features. As these treatments have evolved, the heterogeneity of breast cancer poses a new challenge, since there is no standard gold-therapy suitable for all tumors of the mammary gland. Therefore, contemporary management and research efforts are directed toward specific prognostic and predictive molecular signatures that can guide targeted individualized therapy. The goal of ongoing research in this field is to identify specific molecular targets for developing novel therapeutic approaches. These targets can also serve to improve screening of breast cancer. This review focuses on the role of cancer testis antigens (CTAs) in breast carcinogenesis and explores the potential for development of targeted screening and therapeutic approaches. Normally found in the testes, these antigens are highly correlative with cancers of the breast, skin, and ovaries. These implications have been further corroborated through uncovering the interaction of CTAs with genes and proteins involved in tumor suppression and homeostasis like p53. There is some evidence that these genes can be targeted for early detection in addition to being candidates for cancer immunotherapy.

AB - Breast cancer remains one of the leading causes of death among women across the world. The last few decades have seen significant reduction in mortality owing to earlier detection and better adjuvant treatments that were developed based on clinical staging and morphological features. As these treatments have evolved, the heterogeneity of breast cancer poses a new challenge, since there is no standard gold-therapy suitable for all tumors of the mammary gland. Therefore, contemporary management and research efforts are directed toward specific prognostic and predictive molecular signatures that can guide targeted individualized therapy. The goal of ongoing research in this field is to identify specific molecular targets for developing novel therapeutic approaches. These targets can also serve to improve screening of breast cancer. This review focuses on the role of cancer testis antigens (CTAs) in breast carcinogenesis and explores the potential for development of targeted screening and therapeutic approaches. Normally found in the testes, these antigens are highly correlative with cancers of the breast, skin, and ovaries. These implications have been further corroborated through uncovering the interaction of CTAs with genes and proteins involved in tumor suppression and homeostasis like p53. There is some evidence that these genes can be targeted for early detection in addition to being candidates for cancer immunotherapy.

KW - Biomarker

KW - Breast cancer

KW - Cancer testis antigen

KW - Cancer vaccine

KW - Immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=84867788275&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867788275&partnerID=8YFLogxK

U2 - 10.3109/08830185.2012.723511

DO - 10.3109/08830185.2012.723511

M3 - Article

VL - 31

SP - 302

EP - 320

JO - International Reviews of Immunology

JF - International Reviews of Immunology

SN - 0883-0185

IS - 5

ER -